The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of 6 months ADT/abiraterone acetate plus prednisone (AAP) and definitive radiotherapy (AbiRT) for men with intermediate to high risk localized prostate cancer.
 
Bridget F. Koontz
Consulting or Advisory Role - Blue Earth Diagnostics; GenomeDx; Laguna Pharmaceutical (I)
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Algeta ASA; Exelixis; Medivation; Sanofi
 
Karen E. Hoffman
No Relationships to Disclose
 
Patrick Healy
No Relationships to Disclose
 
Daniel J. George
Honoraria - Bayer; BIOPHARM; Dendreon; Medivation; Novartis; Sanofi
Consulting or Advisory Role - Acceleron Pharma; Astellas Pharma; Bayer; Bristol-Myers Squibb; Celgene; Dendreon; Exelixis; Genentech; GlaxoSmithKline; Innocrin Pharma; Janssen; Medivation; Merck Sharp & Dohme; Myovant Sciences; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Dendreon; Novartis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Genentech/Roche; Medivation; Merck; Pfizer
 
Michael Roger Harrison
Consulting or Advisory Role - Bayer; Exelixis; Genentech; Sanofi
Speakers' Bureau - Genentech
Research Funding - Argos Therapeutics; Bristol-Myers Squibb; Genentech; Medivation/Astellas; Pfizer
 
Tian Zhang
Stock and Other Ownership Interests - Capio Biosciences (I)
Consulting or Advisory Role - Bayer; G1 Therapeutics
Research Funding - Acerta Pharma; Janssen; Merrimack (Inst); Pfizer (Inst); Stem CentRx (Inst)
Other Relationship - Capio BioSciences (I)
 
W. Robert Lee
Patents, Royalties, Other Intellectual Property - UpToDate Editor
 
William R. Berry
No Relationships to Disclose
 
Thomas J Pugh
Travel, Accommodations, Expenses - Augmenix
 
Paul Gettys Corn
Research Funding - Exelixis (Inst); Sanofi (Inst)
 
LuEllen Bratt
Research Funding - Janssen
 
Kellie Shobe
Research Funding - Janssen
 
Blair Thornburg
Research Funding - Janssen
 
Donna M. Allen
Research Funding - Janssen
 
Katie Brummer
Research Funding - Janssen
 
Beth Tojong
No Relationships to Disclose
 
Bridget Hobbs
Research Funding - Janssen
 
Susan Halabi
Consulting or Advisory Role - Dendreon; Eisai; Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Dendreon
 
Andrew J. Armstrong
Honoraria - Dendreon; Janssen Oncology; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Pfizer; Sanofi
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Active Biotech (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation; Sanofi